Stocktoria
Fortrea Holdings Inc. FTRE
Nasdaq · XNAS · stock · Services-Medical Laboratories · website · IPO 2023-06-16
Fortrea Holdings Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $2.7B | $2.7B | $2.8B | $2.8B |
| SG&A expense | $456.4M | $560.7M | $448.1M | $416.1M |
| Operating income | -$872.6M | -$161.9M | $32.0M | $187.1M |
| Interest expense | — | — | $69.8M | $200,000 |
| Income tax | $3.2M | -$3.5M | $1.2M | $41.1M |
| Net income | -$986.2M | -$328.5M | -$25.2M | $186.2M |
| EPS (diluted) | $-10.81 | $-3.67 | $-0.29 | $2.09 |
| Operating cash flow | $113.5M | $262.8M | $168.4M | $82.7M |
| Cash & equivalents | $174.6M | $118.5M | $108.6M | $112.0M |
| Total assets | $2.7B | $3.6B | $4.3B | $4.3B |
| Total liabilities | $2.2B | $2.2B | $2.6B | $945.3M |
| Shareholders' equity | $563.5M | $1.4B | $1.7B | $3.3B |
Source: SEC EDGAR filings · CIK 0001965040 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.